Triple-negative breast cancer (TNBC) is defined by the lack of expression of estrogen (ER) and progesterone (PR) receptors as well as the absence of human epidermal growth factor receptor 2 (HER-2) overexpression/amplification. Here, ERBB2 is linked to triple-negative breast carcinoma.